4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-019046
President and General Counsel sold 20,000 shares at an average $19.43 ($388,638)
- President and General Counsel gave up 11,981 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2018-03-16 | Shares withheld for taxes | −5,495 | $19.91 | $109,405 | 251,372 | D |
| Shandell Jason B. President and General Counsel | 2018-03-17 | Shares withheld for taxes | −6,486 | $19.91 | $129,136 | 244,886 | D |
| Shandell Jason B. President and General Counsel | 2018-03-19 | Sale | −11,707 | $19.37 | $226,767 | 233,179 | D |
| Shandell Jason B. President and General Counsel | 2018-03-20 | Sale | −8,293 | $19.52 | $161,871 | 224,886 | D |
| Open-market sales · 20,000 sh · avg $19.43 · $388,638 | |||||||
Loading xslF345X03/a4.xml…